Company Overview of Novartis Venture Fund
Novartis Venture Fund is an evergreen fund. It is stage agnostic but specializes in investment in seed, early stage, and later stage investments but can also invest in other stages. It focuses on Series A and B for initial investment. The fund prefers to invest in product-and platform-focused biotech, pharmaceutical, medical devices and diagnostics, and healthcare sectors. The fund primarily invests in companies based in the United States and Europe. As the initial or follow-on investments, it typically invests between $10 million and $20 million. It typically takes a 25 percent (app) stake in its portfolio companies along with taking a board seat. It can also make follow on investments depe...
Founded in 1996
41 61 324 32 67
41 61 324 86 79
Key Executives for Novartis Venture Fund
Compensation as of Fiscal Year 2015.
Novartis Venture Fund Key Developments
Novartis Venture Fund Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 11:20 AM
Jul 31 15
Novartis Venture Fund Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 11:20 AM. Venue: Congress Center, Basel, Switzerland. Speakers: Markus Goebel, Partner.
Novartis Venture Fund Presents at Bio-Trinity, May-11-2015
Apr 29 15
Novartis Venture Fund Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.
Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015
Apr 16 15
Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015 . Venue: The Digital Sandbox, 55 Broad Street 4th Floor, New York, NY 10004, United States. Speakers: Christine Brennan, Principal.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries